Genetic Testing Market Players:
- Genentech Inc.
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- Sorenson Genomics
- Abbott Molecular
- Bayer AG
- Biocartis
- BioHelix
- Quest Diagnostics
- Exact Sciences Corporation
- HTG Molecular Diagnostics, Inc.
- PacBio
- GeneDx Holdings Corp.
- BioAro Inc.
- ProPhase Labs, Inc.
The quality and quantity of offerings from the market is evolving with the integration of AI and machine learning (ML). Thus, key players in this field are meticulously engaging their resources to cultivate such advanced portfolio. For instance, in March 2025, GeneDx launched an AI-based decision support tool, Multiscore, to leverage the capabilities of its interpretation platform. The embedded gene ranker is specifically designed to provide faster and more efficient clinical analysis. These revolutionary findings and creations are propelling growth and productivity in this sector and attracting more MedTech pioneers to invest in more innovation cohorts. Such key players are:
Browse key industry insights with market data tables & charts from the report:
Frequently Asked Questions (FAQ)
In the year 2026, the industry size of genetic testing is evaluated at USD 20.06 billion.
The market size for the genetic testing is projected to reach USD 110.45 billion by the end of 2036, expanding at a CAGR of 18.6% during the forecast period, i.e., between 2027-2036.
Asia Pacific genetic testing market is predicted to capture 36% share by 2036, driven by expanding healthcare infrastructure, rising awareness of genetic testing benefits, and improved accessibility in emerging countries.
Key players in the market include Genentech Inc., Sorenson Genomics, Abbott Molecular, Bayer AG, Biocartis, BioHelix, Quest Diagnostics, Exact Sciences Corporation, HTG Molecular Diagnostics, Inc., PacBio.
